Keywords: شیمی درمانی مترونومیک; Antiangiogenesis; IBC; Metronomic chemotherapy; Neoadjuvant chemotherapy; Outcome;
مقالات ISI شیمی درمانی مترونومیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Oral anticancer; Low-dose therapy; Drug delivery; Pemetrexed; Lung cancer; Bile acids;
Keywords: شیمی درمانی مترونومیک; Carcinoma-associated fibroblasts; Metronomic chemotherapy; Cancer stemness; Myeloid-derived suppressor cells;
Keywords: شیمی درمانی مترونومیک; Head neck cancer; Metronomic chemotherapy; Low dose; Survival; Recurrence; Treatment;
Keywords: شیمی درمانی مترونومیک; Low dose; Metronomic chemotherapy; Metastatic colorectal cancer; CRC; colorectal cancer; mCRC; metastatic colorectal cancer; MTD; maximal tolerated dose; PFS; progression-free survival; OS; overall survival; TSP-1; thrombospondin-1;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Cancer; Definition of metronomic chemotherapy; Biomarkers;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Metastatic breast cancer; Oral vinorelbine;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Mathematical models; Cancer therapy; Tumor microenvironment; Optimal control;
Keywords: شیمی درمانی مترونومیک; Therapeutic resistance; Chemoresistance; Metronomic chemotherapy; Antivascular tumor therapy;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Low-dose chemotherapy; Pancreatic cancer; Pancreatic adenocarcinoma; Therapeutic efficacy;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Angiogenesis; Antitumor immunity; Endothelial cell; Immunosuppression;
Keywords: شیمی درمانی مترونومیک; Dosing schedule; Liposomes; Maximum tolerated dose; Metronomic chemotherapy; Nanoparticles; Tumor priming;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Immunotherapy; Cancer therapy;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Metastasis; Animal models; Antiangiogenesis; Vessel co-option; Immunotherapy;
Keywords: شیمی درمانی مترونومیک; Nasopharyngeal carcinoma; Metronomic chemotherapy;
Keywords: شیمی درمانی مترونومیک; Metronomic therapy; Neuroendocrine tumors; NET; Low dose; Anti-angiogenic; Metronomic chemotherapy;
Keywords: شیمی درمانی مترونومیک; Angiosarcoma; Vascular tumor; Metronomic chemotherapy; Propranolol; Adrenergic receptor
Keywords: شیمی درمانی مترونومیک; Tumor priming; Nanomedicine; Metronomic chemotherapy; Tumor vascular normalization; Paclitaxel;
Keywords: شیمی درمانی مترونومیک; Mast cell tumors; Soft tissue sarcomas; Injection site sarcomas; Surgical margins; Surgical oncology; Metronomic chemotherapy;
Keywords: شیمی درمانی مترونومیک; Angiogenesis; Bevacizumab; Chemo-switching; Cyclophosphamide; Immunity; Maintenance; Metronomic chemotherapy; Toxicity
Keywords: شیمی درمانی مترونومیک; Clinical outcome; Dexamethasone; Metronomic chemotherapy; Predictive factor; Stabilizing
Keywords: شیمی درمانی مترونومیک; Cancer; Chemotherapy; Metronomic chemotherapy; Immunoregulation
Keywords: شیمی درمانی مترونومیک; Capecitabine; CTX; Colorectal cancer; Metronomic chemotherapy; Anti-angiogenesis
Keywords: شیمی درمانی مترونومیک; Hepatocellular carcinoma; Active immunotherapy; Cancer vaccine; Tumor antigen discovery; Metronomic chemotherapy;
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Low-dose chemotherapy; Anti-angiogenesis; Systematic review;
Keywords: شیمی درمانی مترونومیک; Cancer; Metronomic chemotherapy; Angiogenesis; Tumour growth; Differential equations
Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
Keywords: شیمی درمانی مترونومیک; Cervical cancer; Metronomic chemotherapy; Bevacizumab;
Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens
Keywords: شیمی درمانی مترونومیک; Pharmacokinetics; Pharmacodynamics; Modelization; Multi-criteria decision-making; Metronomic chemotherapy;
Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment
Keywords: شیمی درمانی مترونومیک; Oral chemotherapy; Metronomic chemotherapy; Chk1 inhibitor; p53-deficient breast cancer; Doxorubicin; Synthetic lethality; MK-8776; Breast cancer;
Chlorambucil loaded in mesoporous polymeric microspheres as oral sustained release formulations with enhanced hydrolytic stability
Keywords: شیمی درمانی مترونومیک; Chlorambucil; Mesoporous polymeric microspheres; Metronomic chemotherapy; Oral formulation; Sustained release;
Mini-reviewATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy
Keywords: شیمی درمانی مترونومیک; ABC transporters; Tumors endothelial cells; Drug resistance; Anti-angiogenic therapy; Metronomic chemotherapy; ABC; ATP-binding cassette; CM; conditioned medium; EC; endothelial cell; EGF; epithelial growth factor; FGF; fibroblast growth factor; HMVEC; hu
Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Non-small cell lung cancer; Bevacizumab;
Mini-reviewMetronomics in the neoadjuvant and adjuvant treatment of breast cancer
Keywords: شیمی درمانی مترونومیک; Breast cancer; Adjuvant treatment; Neoadjuvant treatment; Metronomic chemotherapy; Immunomodulation; Triple negative;
The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine
Keywords: شیمی درمانی مترونومیک; GEM; gemcitabine; CAP; capecitabine; TRF; telomere restriction fragment; TRF2; Telomere; Metronomic chemotherapy;
Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients
Keywords: شیمی درمانی مترونومیک; Ovarian cancer; Regulatory T cells; Metronomic chemotherapy
Oral uracil and tegafur as postoperative adjuvant metronomic chemotherapy in patients with advanced oral squamous cell carcinoma
Keywords: شیمی درمانی مترونومیک; circulating endothelial progenitor cell; metronomic chemotherapy; oral squamous cell carcinoma; uracil-tegafur;
Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
Keywords: شیمی درمانی مترونومیک; Triple-negative breast cancer; Metronomic chemotherapy; Capecitabine; Extended adjuvant treatment
Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication
Keywords: شیمی درمانی مترونومیک; Tyrosinase vaccine; Interleukin-12; Metronomic chemotherapy; Immunotherapy; Melanoma;
Case ReportMetronomic cyclophosphamide: An alternative treatment for hepatic epithelioid hemangioendothelioma
Keywords: شیمی درمانی مترونومیک; Hemangioendothelioma; Metronomic chemotherapy; Cyclophosphamide; Epithelioid tumor; Endothelial cells; Anti-angiogenic;
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
Keywords: شیمی درمانی مترونومیک; Sunitinib; Bevacizumab; Metronomic chemotherapy; Standard chemotherapy; Metastasis; Mouse models of cancer
Thrombospondin-1 and pigment epithelium-derived factor enhance responsiveness of KM12 colon tumor to metronomic cyclophosphamide but have disparate effects on tumor metastasis
Keywords: شیمی درمانی مترونومیک; Thrombospondin-1; Pigment epithelium-derived factor (PEDF); Angiogenesis; Metronomic chemotherapy; Innate anti-tumor immunity
The use of nanoparticulate delivery systems in metronomic chemotherapy
Keywords: شیمی درمانی مترونومیک; Nanoparticles; Metronomic chemotherapy; Tumor angiogenesis; Docetaxel; Flt-1; SP5.2
Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab
Keywords: شیمی درمانی مترونومیک; Macrocytosis; Metastatic breast cancer; Predictive factor; Angiogenesis; Metronomic chemotherapy; Bevacizumab
Metformin as a Novel Component of Metronomic Chemotherapeutic Use: A Hypothesis
Keywords: شیمی درمانی مترونومیک; AMPK; cancer; metabolism; metformin; metronomic chemotherapy
Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
Keywords: شیمی درمانی مترونومیک; Capecitabine; Clinical benefit rates; Metastatic breast cancer; Metronomic chemotherapy; Efficacy; Tolerability
Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
Keywords: شیمی درمانی مترونومیک; Bevacizumab; Erlotinib; Metronomic chemotherapy
Metronomic chemotherapy in metastatic breast cancer: Impact on VEGF
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; MBC; VEGF
L'immunothérapie : une nouvelle approche dans la prise en charge du cancer de prostate résistant à la castration
Keywords: شیمی درمانی مترونومیک; cancer de prostate; immunothérapie; vaccin; anticorps monoclonal; chimiothérapie métronomique; prostate cancer; immunotherapy; monoclonal antibodies; vaccine; metronomic chemotherapy;
Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
Keywords: شیمی درمانی مترونومیک; Cyclophosphamide; Metronomic chemotherapy; Anti-angiogenic drug; Immuno-stimulant drug; Micro-environment
Metronomic therapy for gynecologic cancers
Keywords: شیمی درمانی مترونومیک; antiangiogenesis agent; cytotoxic drugs; gynecologic cancer; metronomic chemotherapy